COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE

Clinical Trial: 11-282

Trial Status: Open
Trial Type: Hodgkin Lymphoma
Disease Type: Hodgkin Disease
Trial ID 11-282
Sponsor ID

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

Principal Investigator
Dipti Patel-Donnelly, MD
3 Locations


Arlington Infusion Suite

Fairfax Office

Gainesville Office

Learn More About This Trial
Other Relevant Trials